Anti-HER2/neu peptide producing vector system for biologic therapy - Is it possible to mass-produce the peptide?

Byeong Woo Park, Ki Suk Kim, Min Kyu Heo, Kyong Sik Lee, Eun Kyung Kim, Kyung Sup Kim

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)


A humanized monoclonal antibody against HER2 has been using in a clinical setting and has been shown to possess therapeutic properties. A mimetic peptide against HER2 was also reported to bind to the HER2 receptor with some therapeutic potential. Based on a previous report and the sequence of Herceptin, we designed oligonucleotides of anti-HER2 mimetic peptides, named V2 and V3 peptides, in order to develop a peptide-producing vector system for biologic therapy against HER2-overexpressing cancers. We also adopted the sequence of a previously reported mimetic peptide, V1 (Park BW et al. Nat. Biotechnol, 2000, 18:194-198), as a reference peptide. We examined the effects of the V2 and V3 peptides against the HER2-overexpressing cell lines, SK-BR-3 and T6-17. Transient transfection of the construct expressing V1 and V2 inhibited cell proliferation in HER2-overexpressing cell lines by 20 - 30%, but had no effect on the HER2-negative NIH3T3 cells. The proliferation inhibition shown by V2 was slightly better than that shown by V1. Recombinant peptides V2 and V3 were produced on a large scale in an E. coli system, and the V2 peptide showed anti-HER2-specific tumor cell proliferation inhibition of 10% to 30%. Current results suggest that anti-HER2 mimetic peptides, overexpressed by a constitutive promoter or produced in an E. coli system, could specifically inhibit the proliferation of HER2-expressing cancer cells. Further efforts to augment the biologic specificity and efficacy and to develop new technologies for the purification of the peptide from the E coli system are needed.

Original languageEnglish
Pages (from-to)58-64
Number of pages7
JournalYonsei medical journal
Issue number1
Publication statusPublished - 2003 Feb

All Science Journal Classification (ASJC) codes

  • Medicine(all)


Dive into the research topics of 'Anti-HER2/neu peptide producing vector system for biologic therapy - Is it possible to mass-produce the peptide?'. Together they form a unique fingerprint.

Cite this